The Impact of Induction With Azacitidine and Venetoclax Versus Intensive Chemotherapy on Outcomes After Allogeneic Hematopoietic Cell Transplantation for Newly Diagnosed Acute Myeloid Leukemia.

Wirk B, Hawila R.

Open source

DOI
10.14740/jh2217
Published
2026-08-31
Container
J Hematol
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.14740/jh2217,
  title = {The Impact of Induction With Azacitidine and Venetoclax Versus Intensive Chemotherapy on Outcomes After Allogeneic Hematopoietic Cell Transplantation for Newly Diagnosed Acute Myeloid Leukemia.},
  author = {Wirk B and  Hawila R.},
  year = {2026},
  journal = {J Hematol},
  doi = {10.14740/jh2217},
  url = {https://doi.org/10.14740/jh2217}
}

RIS

TY  - JOUR
TI  - The Impact of Induction With Azacitidine and Venetoclax Versus Intensive Chemotherapy on Outcomes After Allogeneic Hematopoietic Cell Transplantation for Newly Diagnosed Acute Myeloid Leukemia.
AU  - Wirk B
AU  -  Hawila R.
PY  - 2026
JO  - J Hematol
DO  - 10.14740/jh2217
UR  - https://doi.org/10.14740/jh2217
ER  - 

APA

B, W., & R., H. (2026). The Impact of Induction With Azacitidine and Venetoclax Versus Intensive Chemotherapy on Outcomes After Allogeneic Hematopoietic Cell Transplantation for Newly Diagnosed Acute Myeloid Leukemia.. J Hematol. https://doi.org/10.14740/jh2217

Source records